August news: Catapult network granted £780m in additional funding

In this newsletter you can: Register for our webinar and explore price and access implications of cost-utility and budget impact methodologies, find out how we have worked with you to support industry growth in our Annual Review 2018 and see what additional funding will mean for CGT Catapult and the Catapult network.

This month we published our Annual Review 2018 where you can take a look at the projects we have been working on over the past year and the impact we have had so far in the building the advanced therapies ecosystem and the UK industry. We also welcomed a delegation from HM Treasury to our development laboratories in Guy's Hospital, London.

It was also announced that the UK Government have granted the Catapult Network an additional £780m in funding. The additional funding will support the CGT Catapult in its mission of providing end-to-end support to businesses and organisations to translate early-stage research into commercially viable and investable cell and gene therapies.

Whether you will be in Europe, US or Japan, we look forward to meeting you at one of our upcoming events. Finally, sign up to our upcoming webinar and explore implications of the cost-utility and budget impact methodologies with our health economics team.